StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Trading Down 0.3 %
NASDAQ MDRX opened at $9.40 on Friday. The business’s fifty day moving average is $9.52 and its 200 day moving average is $9.14. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $13.62.
Institutional Trading of Veradigm
Several hedge funds have recently made changes to their positions in MDRX. Innealta Capital LLC bought a new stake in Veradigm in the second quarter worth $38,000. Tyro Capital Management LLC purchased a new stake in shares of Veradigm in the first quarter valued at $9,055,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Veradigm by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after acquiring an additional 95,291 shares during the last quarter.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- The How And Why of Investing in Oil Stocks
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- 5 discounted opportunities for dividend growth investors
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
